Amicus Therapeutics Shares Halted, News Pending
Portfolio Pulse from Benzinga Newsdesk
Shares of Amicus Therapeutics have been halted due to pending news. The nature of the news is currently unknown.
September 28, 2023 | 12:29 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Amicus Therapeutics' shares have been halted due to pending news. The impact on the stock price will depend on the nature of the news.
The halt in trading of Amicus Therapeutics' shares indicates that there is significant news pending. The nature of this news could have a major impact on the stock's price, but without further information, it's impossible to predict the direction of this impact.
CONFIDENCE 50
IMPORTANCE 100
RELEVANCE 100